Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2015-01-08 10:27 (2567 d 14:40 ago) – Posting: # 14251
Views: 27,051

Dear Cher!

» Sorry to ask again, but I can't see any contradiction between point 1 and 3.

Once again slowly to take notes:
Suppose you have a subject with two periods absolved, in both Reference applied.
According to your rules, point 1, you don't have at least one Reference and one Test applied, so you will not include such a subject in the pharmacokinetic and statistical analysis.
Full stop.

Regards,

Detlew

Complete thread:

Activity
 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time: Wednesday 01:08 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5